Rare diseases
Investigational molecules
Locations
852 Winter Street Suite 250, 02451-1439, United States
Zenas Biopharma (USA) LLC funds clinical research in IgG4-related disease, systemic lupus erythematosus, and warm autoimmune hemolytic anemia, with a clear focus on conditions driven by immune dysregulation and inflammatory activity.
Its research interests include disease control, flare prevention, anemia-related outcomes, and the management of immune-mediated tissue involvement.
Zenas Biopharma (USA) LLC runs clinical trials in conditions such as Primary progressive multiple sclerosis, Systemic lupus erythematosus, Relapsing-remitting multiple sclerosis, Immunoglobulin G4 related disease, among others.
Clinical trials run by this sponsor – those enrolling participants first.
AustriaAustria
BelgiumAustria
France
ItalyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
